Studies have reported that fasting blood
sugar level is independently associated with the risk of cancer onset but in
accordance to a recent study published in the Journal of Diabetes which
has found that long-term changes in fasting blood sugar are positively
associated with the risk of cancer in type 2 diabetes patients.
The researchers collected data from 46 761
patients with T2DM aged between 20-80 years. To describe fasting blood sugar
variability, four indicators were adopted, including coefficient of variation
(CV), average real variability (ARV), standard deviation (SD), and variation
independent of the mean (VIM). The association between long-term fasting blood
sugar variability and cancer risk was investigated. The interactive effect of
FBG variability was determined with hypertension and fasting blood sugar -mean
with hypertension on the risk of cancer, respectively.
For more details, check out the link given below:
Fasting Blood Sugar Variability Linked With Cancer Risk In Patients With Type 2 Diabetes